EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibiofilm activity of a chionodracine‐derived peptide by NMR ‐based metabolomics of cell‐free supernatant of Acinetobacter baumannii clinical strains

Fernando Porcelli, Enrico Landi, Francesco Maiurano, Irene Paris, Rosanna Papa, Marco Artini, Laura Selan, Stefano Borocci, Francesco Buonocore, Esther Imperlini iD

FEBS Open Bio · 2025

DOI: 10.1002/2211-5463.70156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Open Bio, 2025. Verfasst von Fernando Porcelli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department for Innovation in Biological, Agro-Food and Forest Systems, University of Tuscia, Viterbo, Italy. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Biofilms, Metabolomics, Anti-Bacterial Agents. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research funded by the European Union - NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ability of Acinetobacter baumannii to form biofilm is correlated with its antimicrobial resistance. The identification of antimicrobial drugs acting on biofilm is crucial to develop effective therapies. Previously, we determined that a chionodracine‐derived peptide, KHS‐Cnd, was able to impair A. baumannii biofilm formation. Here, to investigate the physiological changes underlying this activity, extracellular metabolite profiles of four A. baumannii strains were analyzed by NMR during biofilm formation in the presence of KHS‐Cnd. Metabolites involved in biofilm energy metabolism were found extracellularly after KHS‐Cnd treatment. Significantly altered pathways were associated with glyoxylate/dicarboxylate and branched‐chain/aromatic amino acid metabolism. Overall, differences in extracellular metabolites reflect modifications of biofilm metabolism due to peptide treatment, thus highlighting its therapeutic potential against A. baumannii biofilm‐sustained infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiBiofilmsMetabolomicsAnti-Bacterial AgentsPeptidesMagnetic Resonance SpectroscopyHumansMicrobial Sensitivity TestsAcinetobacter Infections

Stichwörter der Autor:innen

Acinetobacter baumanniiNMR‐based metabolomicsantimicrobial peptidebiofilmextracellular metabolitesmetabolic pathways

Substanzen

Anti-Bacterial AgentsPeptides

Autor:innen und Institutionen

  • Department for Innovation in Biological, Agro-Food and Forest Systems, University of Tuscia, Viterbo, Italy.
  • Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.

ORCID-Profile: Esther Imperlini

Förderung

  • Italian Ministry of University and Research funded by the European Union - NextGenerationEU

Zitieren

APA

Porcelli, F., Landi, E., Maiurano, F., Paris, I., Papa, R., Artini, M., Selan, L., Borocci, S., Buonocore, F., & Imperlini, E. (2025). Antibiofilm activity of a chionodracine‐derived peptide by NMR ‐based metabolomics of cell‐free supernatant of Acinetobacter baumannii clinical strains. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70156

Vancouver

Porcelli F, Landi E, Maiurano F, Paris I, Papa R, Artini M, et al. Antibiofilm activity of a chionodracine‐derived peptide by NMR ‐based metabolomics of cell‐free supernatant of Acinetobacter baumannii clinical strains. FEBS Open Bio. 2025. doi:10.1002/2211-5463.70156

BibTeX
@article{Porcelli2025,
  author = {Porcelli, Fernando and Landi, Enrico and Maiurano, Francesco and Paris, Irene and Papa, Rosanna and Artini, Marco and Selan, Laura and Borocci, Stefano and Buonocore, Francesco and Imperlini, Esther},
  title = {Antibiofilm activity of a chionodracine‐derived peptide by NMR ‐based metabolomics of cell‐free supernatant of Acinetobacter baumannii clinical strains},
  journal = {FEBS Open Bio},
  year = {2025},
  doi = {10.1002/2211-5463.70156}
}
Kostenlos starten →